Where to buy epithalon.

You can buy epithalon from research-supply vendors online. That's the only route in the West: no pharmacy stocks it and no prescriber can write for it. Where to buy epithalon comes down to finding a vendor honest about a compound where one Russian lab produced roughly 75% of the efficacy literature and zero modern Western trials exist.

Epithalon

Referenced in this guide

Batch-matched COAHPLC + mass specResearch use only

The Epithalon referenced throughout this article, supplied as a research compound with a certificate of analysis matched to the lot you receive — the check this site argues you should hold any supplier to.

Shop Epithalon

Where can you buy epithalon?

Epithalon comes from research-supply vendors online, sold as a reference compound under Research Use Only labeling. In Russia it's prescribed clinically under a different regulatory framework, but that framework doesn't reach Western buyers.

• Research-supply vendor: The only Western route. Lyophilized epithalon powder, no prescription, no regulator standing behind the vial.
• Compounding pharmacy: Closed in practice. The FDA has never categorized epithalon under 503A, and no compounding-pharmacy interest exists to force the question.
• Retail pharmacy on prescription: Closed in the US and EU. Neither the FDA nor the EMA has approved epithalon for any indication.

So you're choosing a vendor, not a channel. We'd judge epithalon vendors first on how they describe the evidence, because that's where this compound's marketing goes wrong.

Six vendors, all checked on 13 August 2026 against what each will show you before you pay: a third-party certificate you can open, and whether the testing lab is named in the vendor's own copy or only inside the PDF. We did not verify epithalon prices, so there is no price column here — pricing across these same vendors is benchmarked on BPC-157 in our full vendor comparison, where the spread runs $6.30–$12.45 per mg. Stock varies by compound, so check each catalogue for epithalon.

Three caveats travel with that table. Peptriva and Red Rock sell 10 mg vials only, so their per-milligram figures in the BPC-157 benchmark are not comparable with a 5 mg row. Swiss Chems sells its BPC-157 as the arginine salt rather than the plain peptide, so it is not a like-for-like product. And Red Rock publishes no certificate of analysis at all, despite advertising verified COAs. Where To Buy Peptides earns a commission on purchases made through its links, Peptriva included — see our disclosure.

The identity check specific to epithalon: CAS 307297-39-8, a molecular weight of about 390 g/mol, and the sequence written out as Ala-Glu-Asp-Gly.

What is epithalon, exactly?

Epithalon’s sequence is four amino acids: Ala-Glu-Asp-Gly, written AEDG. The Khavinson group synthesized it in the 1990s based on the amino-acid composition of epithalamin, a bovine pineal-gland extract they’d been working with since the 1970s.

The play was simple. Take an active extract. Reduce its bioactivity down to the smallest peptide fragment that still worked. That fragment turned out to be a four-amino-acid sequence you could synthesize at scale, as Araj and colleagues recount.

The epithalon research lineage is real and deep. The cell-culture evidence base supporting consumer marketing is narrower than that lineage suggests.

A vendor parroting Khavinson efficacy claims without acknowledging the single-source story is either uninformed or selling marketing. For the full walk-through, see our complete epithalon guide and telomerase mechanism article.

What should you check before buying epithalon?

Check epithalon for CAS 307297-39-8, a mass-spec peak at 391.2, a price inside the $60–$150 band, and vendor copy that doesn't claim proven human results. The general eight peptide-buyer criteria apply on top. These four matter more here:

1. The CoA must show CAS 307297-39-8 and mass-spec at 391.2

Epithalon's four-amino-acid sequence is unambiguous to a peptide chemist. But that simplicity creates a counterintuitive risk. Epithalon is one of the easiest peptides on the market to fake, and crude or partially purified material can pass casual inspection.

A credible CoA shows:

• Sequence Ala-Glu-Asp-Gly on the identity line.
• CAS 307297-39-8.
• Mass-spec at observed [M+H]⁺ 391.2, within 0.3 Da of the theoretical 390.4 g/mol.

Cross-check the CAS against PubChem in 30 seconds. Missing CAS, missing sequence, or wrong mass means the wrong molecule.

2. The Western trial base is thin

Epithalon vendor copy is itself a signal. The honest framing is straightforward. Real cell-culture biology exists, mostly from the Khavinson group, with one important independent confirmation from Brunel University London in 2025, per Al-Dulaimi and colleagues.

Russian-language clinical literature exists but hasn't been replicated under Western methodology. Zero modern Western controlled trials have been published.

Vendors making strong human-efficacy claims are either unaware of the evidence base or copying marketing that doesn't track it. “Telomere extension in humans.” “Clinically proven aging reversal.” Either way, look elsewhere.

3. Pricing should match the chemistry, not the marketing

Epithalon costs $60–$100 for a 10 mg vial and $100–$150 for 20 mg. Four amino acids, no modifications, a well-established synthesis route. It's one of the lowest-cost research peptides to make. The 2026 retail bands:

• 10 mg vial: $60–$100, or $6–$10 per mg.
• 20 mg vial: $100–$150, or $5–$7.50 per mg.
• 50 mg vial: $130–$170, or $2.60–$3.40 per mg. Best per-mg value.
• Multi-vial tiers: 10–25% off for 3- or 6-pack orders.

Above $200 per 20 mg is longevity-marketing premium, not chemistry. “Biohacking”-positioned vendors often price 2–3x above the synthesis-anchored range. The four-amino-acid chemistry doesn’t support that markup.

Below $40 per 10 mg deserves a question in the other direction. HPLC purification has a real cost, and the cheap end usually skips it.

4. “Russian-sourced” or “Khavinson-grade” is marketing language

Most authentic epithalon in the Western research market comes from custom-peptide manufacturers synthesizing against the published AEDG sequence. There's no Khavinson-affiliated supply chain exporting to Western buyers, and the Russian framework under which those peptides are prescribed doesn't extend to export.

Vendors using “Russian-sourced” positioning aren’t describing a real supply-chain difference. They’re using marketing language. What matters is whether the four-amino-acid identity is verified by mass-spec on a third-party CoA.

Is epithalon legal to buy?

Yes. Epithalon is legal to buy as a research reference compound. It isn't FDA-approved for any therapeutic use and isn't recognized as a drug in the US.

There's no 503A compounding categorization either. The FDA has treated it as a non-issue, because epithalon has no FDA-engaged sponsor and no compounding-pharmacy interest. The practical picture:

• Research-compound sales are legal under 21 CFR § 809.10(b)(9) Research Use Only labeling.
• Sales for human consumption are illegal. That would be an unapproved drug entering interstate commerce.
• EMA hasn’t approved epithalon for any indication.
• Russia uses epithalon and related Khavinson peptides clinically under a different regulatory framework.
• WADA hasn’t listed epithalon as prohibited as of 2026, but the broader peptide-bioregulator category is increasingly monitored.

What are the red flags when buying epithalon?

The epithalon red flag we weigh heaviest is a claim of proven human telomere extension, because no modern Western trial supports one. Nine warning signs we’d skip:

• “Telomere extension proven in humans” or “clinically proven senescence reversal.” No modern Western trial supports these claims.
• “Russian-sourced” or “Khavinson-grade” positioning. No Khavinson-affiliated supply chain exports to the Western market. Marketing language.
• “Epithalon Plus”, “Advanced”, or “Pineal Complex” variants. Anything without a disclosed structural change isn’t the published AEDG sequence.
• Missing CAS 307297-39-8 on the CoA. The CAS is the molecule’s ID. Its absence is a critical gap.
• Mass-spec result not at 391.2. Wrong mass means wrong molecule.
• Pre-mixed liquid at room temperature. Powder survives shipping. Liquid degrades fast.
• Capsules, sublingual sprays, or patches. None validated in any published study.
• Clinical claims about cancer prevention or treatment. Especially concerning given the 2025 Brunel ALT-activation finding in cancer cells.
• Vendor’s in-house QC instead of third-party testing. Independent ISO 17025 verification is the standard.

Epithalon

50 mg ≥99% pure Lyophilized

Ala-Glu-Asp-Gly tetrapeptide, CAS 307297-39-8. The same reference compound used across the cited cell-culture studies and the Khavinson-group mechanistic literature. COA with HPLC trace and mass-spec ships with every order.

Learn more

Frequently asked questions

Is epithalon legal to buy in the USA?

Yes. Epithalon is legal to buy as a research reference compound under 21 CFR § 809.10(b)(9). It's not FDA-approved and not recognized as a drug. Selling it for human consumption is illegal. Buying it as research material isn't. Unlike BPC-157, epithalon has no FDA 503A categorization, and WADA hasn't listed it as prohibited.

How much should third-party tested epithalon cost?

$60–$100 for a 10 mg vial, $100–$150 for 20 mg, $130–$170 for 50 mg. Below that range, purity is the trade-off. Above it, you’re paying longevity-marketing premium instead of synthesis cost.

Does epithalon actually extend human lifespan?

No modern Western trial has shown that. The lifespan claims trace to Russian-language reports from the Khavinson group, which haven’t been replicated under Western methodology and aren’t in PubMed. The 2025 Brunel paper independently confirmed telomerase activation in normal cells, but cell-culture activation isn’t validated human lifespan extension. The same paper flagged ALT-pathway activation in cancer cells.

How credible are the Khavinson Russian aging trials?

The Khavinson group has published Russian-language clinical reports on epithalon in elderly cohorts since the 1980s, claiming mortality reduction and age-related disease improvements. The studies ran under the Russian regulatory framework, which sets different approval standards from the FDA or EMA.

Those papers are largely not indexed in PubMed and not accessible in English. Real Russian clinical experience exists. Western replication doesn't. After several decades, that absence is itself a signal. See our epithalon Russian aging trials article.

How does the telomerase mechanism work?

Epithalon is proposed to boost hTERT mRNA and telomerase activity, which extends telomeres in normal cells. The 2025 Brunel paper reported dose-dependent extension in normal epithelial cells and fibroblasts. It also flagged ALT-pathway activation in two breast cancer cell lines, 21NT and BT474. That cancer-cell finding raises theoretical concerns consumer marketing rarely discusses.

How should epithalon be stored?

Store the freeze-dried powder at −20°C for long-term storage. It’s stable at 2–8°C for shorter periods. After reconstitution in bacteriostatic water, in-use stability at 2–8°C is 1–4 weeks. The four-amino-acid sequence is more stable than longer peptides but should still be protected from light and freeze-thaw cycles.